 | • レポートコード：QFJ1-5895 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・非小細胞肺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・非小細胞肺がん治療薬の種類別市場規模と予測2016-2027（生物製剤、小分子標的療法、化学療法、その他） ・非小細胞肺がん治療薬の用途別市場規模と予測2016-2027（肺腺癌、肺扁平上皮癌、大細胞肺癌） ・非小細胞肺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・非小細胞肺がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・非小細胞肺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非小細胞肺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・非小細胞肺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd、Merck & Co., Inc.） ・結論 |
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.
The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs market growth during the forecast period. With the increase in the prevalence of lung cancer, the need for a strong pipeline of disease-modifying drugs is also increasing.
Market Analysis and Insights: Global Non-small Cell Lung Cancer Drugs Market
The global Non-small Cell Lung Cancer Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-small Cell Lung Cancer Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-small Cell Lung Cancer Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-small Cell Lung Cancer Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-small Cell Lung Cancer Drugs market.
Global Non-small Cell Lung Cancer Drugs Scope and Market Size
Non-small Cell Lung Cancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-small Cell Lung Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biologics
Small Molecule Targeted Therapy
Chemotherapy
Other
Segment by Application
Lung Adenocarcinoma
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Small Molecule Targeted Therapy
1.2.4 Chemotherapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Non-small Cell Lung Cancer Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lung Adenocarcinoma
1.3.3 Squamous Cell Lung Carcinoma
1.3.4 Large-cell Lung Carcinoma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-small Cell Lung Cancer Drugs Market Perspective (2016-2027)
2.2 Non-small Cell Lung Cancer Drugs Growth Trends by Regions
2.2.1 Non-small Cell Lung Cancer Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-small Cell Lung Cancer Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Non-small Cell Lung Cancer Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Non-small Cell Lung Cancer Drugs Industry Dynamic
2.3.1 Non-small Cell Lung Cancer Drugs Market Trends
2.3.2 Non-small Cell Lung Cancer Drugs Market Drivers
2.3.3 Non-small Cell Lung Cancer Drugs Market Challenges
2.3.4 Non-small Cell Lung Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-small Cell Lung Cancer Drugs Players by Revenue
3.1.1 Global Top Non-small Cell Lung Cancer Drugs Players by Revenue (2016-2021)
3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Non-small Cell Lung Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-small Cell Lung Cancer Drugs Revenue
3.4 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio
3.4.1 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-small Cell Lung Cancer Drugs Revenue in 2020
3.5 Non-small Cell Lung Cancer Drugs Key Players Head office and Area Served
3.6 Key Players Non-small Cell Lung Cancer Drugs Product Solution and Service
3.7 Date of Enter into Non-small Cell Lung Cancer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-small Cell Lung Cancer Drugs Breakdown Data by Type
4.1 Global Non-small Cell Lung Cancer Drugs Historic Market Size by Type (2016-2021)
4.2 Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2022-2027)
5 Non-small Cell Lung Cancer Drugs Breakdown Data by Application
5.1 Global Non-small Cell Lung Cancer Drugs Historic Market Size by Application (2016-2021)
5.2 Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-small Cell Lung Cancer Drugs Market Size (2016-2027)
6.2 North America Non-small Cell Lung Cancer Drugs Market Size by Type
6.2.1 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021)
6.2.2 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027)
6.2.3 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2027)
6.3 North America Non-small Cell Lung Cancer Drugs Market Size by Application
6.3.1 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021)
6.3.2 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027)
6.3.3 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2027)
6.4 North America Non-small Cell Lung Cancer Drugs Market Size by Country
6.4.1 North America Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021)
6.4.2 North America Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-small Cell Lung Cancer Drugs Market Size (2016-2027)
7.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type
7.2.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021)
7.2.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027)
7.2.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2027)
7.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Application
7.3.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021)
7.3.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027)
7.3.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2027)
7.4 Europe Non-small Cell Lung Cancer Drugs Market Size by Country
7.4.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021)
7.4.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size (2016-2027)
8.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type
8.2.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application
8.3.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region
8.4.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-small Cell Lung Cancer Drugs Market Size (2016-2027)
9.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type
9.2.1 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2027)
9.3 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application
9.3.1 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2027)
9.4 Latin America Non-small Cell Lung Cancer Drugs Market Size by Country
9.4.1 Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size (2016-2027)
10.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type
10.2.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application
10.3.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country
10.4.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Introduction
11.1.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Introduction
11.3.4 Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 F. Hoffmann-La Roche Ltd Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Introduction
11.4.4 F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Ltd Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Introduction
11.5.4 Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021)
11.5.5 Merck & Co., Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Small Molecule Targeted Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Other
Table 6. Global Non-small Cell Lung Cancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Non-small Cell Lung Cancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-small Cell Lung Cancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Non-small Cell Lung Cancer Drugs Market Share by Regions (2016-2021)
Table 10. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Non-small Cell Lung Cancer Drugs Market Share by Regions (2022-2027)
Table 12. Non-small Cell Lung Cancer Drugs Market Trends
Table 13. Non-small Cell Lung Cancer Drugs Market Drivers
Table 14. Non-small Cell Lung Cancer Drugs Market Challenges
Table 15. Non-small Cell Lung Cancer Drugs Market Restraints
Table 16. Global Non-small Cell Lung Cancer Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Non-small Cell Lung Cancer Drugs Market Share by Players (2016-2021)
Table 18. Global Top Non-small Cell Lung Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2020)
Table 19. Ranking of Global Top Non-small Cell Lung Cancer Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Non-small Cell Lung Cancer Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-small Cell Lung Cancer Drugs Product Solution and Service
Table 23. Date of Enter into Non-small Cell Lung Cancer Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Non-small Cell Lung Cancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Non-small Cell Lung Cancer Drugs Product
Table 66. AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Bristol-Myers Squibb Company Company Details
Table 69. Bristol-Myers Squibb Company Business Overview
Table 70. Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Product
Table 71. Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Company Recent Development
Table 73. Eli Lilly and Company Company Details
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Non-small Cell Lung Cancer Drugs Product
Table 76. Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly and Company Recent Development
Table 78. F. Hoffmann-La Roche Ltd Company Details
Table 79. F. Hoffmann-La Roche Ltd Business Overview
Table 80. F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Product
Table 81. F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021) & (US$ Million)
Table 82. F. Hoffmann-La Roche Ltd Recent Development
Table 83. Merck & Co., Inc. Company Details
Table 84. Merck & Co., Inc. Business Overview
Table 85. Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Product
Table 86. Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2016-2021) & (US$ Million)
Table 87. Merck & Co., Inc. Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-small Cell Lung Cancer Drugs Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Small Molecule Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Other Features
Figure 6. Global Non-small Cell Lung Cancer Drugs Market Share by Application: 2020 VS 2027
Figure 7. Lung Adenocarcinoma Case Studies
Figure 8. Squamous Cell Lung Carcinoma Case Studies
Figure 9. Large-cell Lung Carcinoma Case Studies
Figure 10. Non-small Cell Lung Cancer Drugs Report Years Considered
Figure 11. Global Non-small Cell Lung Cancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Non-small Cell Lung Cancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Non-small Cell Lung Cancer Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Non-small Cell Lung Cancer Drugs Market Share by Regions (2022-2027)
Figure 15. Global Non-small Cell Lung Cancer Drugs Market Share by Players in 2020
Figure 16. Global Top Non-small Cell Lung Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Non-small Cell Lung Cancer Drugs Revenue in 2020
Figure 18. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Non-small Cell Lung Cancer Drugs Market Share by Type (2016-2027)
Figure 22. North America Non-small Cell Lung Cancer Drugs Market Share by Application (2016-2027)
Figure 23. North America Non-small Cell Lung Cancer Drugs Market Share by Country (2016-2027)
Figure 24. United States Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-small Cell Lung Cancer Drugs Market Share by Type (2016-2027)
Figure 28. Europe Non-small Cell Lung Cancer Drugs Market Share by Application (2016-2027)
Figure 29. Europe Non-small Cell Lung Cancer Drugs Market Share by Country (2016-2027)
Figure 30. Germany Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Share by Region (2016-2027)
Figure 40. China Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-small Cell Lung Cancer Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Non-small Cell Lung Cancer Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Non-small Cell Lung Cancer Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2016-2021)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2016-2021)
Figure 63. Merck & Co., Inc. Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…- 非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…
- 世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年） Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women. Market Analysis and Insights: Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market The glo…
- 世界の肺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lung cancer Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の腫瘍小分子薬市場規模・現状・予測（2021年-2027年） Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Market Analysis and Insights: Global Oncology Small Molecule Drugs Market The global Oncology Small Molecule Drugs market …